Moirai Biodesign, a start-up and member of CataloniaBio & HealthTech, has developed a prototype for a device using biosensors to diagnose sepsis from a blood sample in just three hours. 

Amadís Pagès, CEO of Moirai, highlights: “This will allow clinical specialists to make decisions more quickly, as this process normally takes up to five days of laboratory analysis.”

Moirai aims to commercialise the device in hospitals after completing the validation phase. 

Sepsis is a complication of infection and, if not treated in time, leads to multiple organ failure and death. 27-30 million cases are diagnosed each year and 6-9 million of these end up dying.

The company was awarded a €75,000 grant through the ACCIÓ Startup Capital line. 

Photo: Team of Morai Biodesign at the Barcelona Science Park - © PCB